ResearcherCentral South UniversityNo recent work listed

Hui Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9901-8953; OpenAlex author ID A5008388629. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling. Co-author DOI 10.3724/abbs.2022194 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Duo Han · 1 shared paper, 2022 · strength 0.15
- Paper DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling. DOI 10.3724/abbs.2022194 ↗
Xiao Yu · 1 shared paper, 2022 · strength 0.15
- Paper DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling. DOI 10.3724/abbs.2022194 ↗
Wenzhe Gao · 1 shared paper, 2022 · strength 0.15
- Paper DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling. DOI 10.3724/abbs.2022194 ↗
Hongwei Zhu · 1 shared paper, 2022 · strength 0.15
- Paper DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling. DOI 10.3724/abbs.2022194 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.